Literature DB >> 31758828

Strongyloidiasis screening in migrants living in Spain: systematic review and meta-analysis.

Fernando Salvador1, Begoña Treviño2, Pau Bosch-Nicolau1, Núria Serre-Delcor2, Adrián Sánchez-Montalvá1, Inés Oliveira2, Elena Sulleiro3, Mª Luisa Aznar2, Diana Pou2, Augusto Sao-Avilés1, Israel Molina1.   

Abstract

OBJECTIVES: To provide information regarding the prevalence of strongyloidiasis among migrants coming from Strongyloides stercoralis-endemic areas who reside in Spain.
METHODS: Systematic review of the literature and meta-analysis of studies showing prevalence of S. stercoralis infection among migrants from Latin America, Africa, Eastern Europe, Asia and Oceania who reside in Spain. We included articles published until 30 April 2019 without language restriction. The keywords used for the search included 'Strongyloides stercoralis', 'strongyloidiasis', 'Spain', 'screening' and 'migrants'.
RESULTS: Twenty-four studies were included in the review and meta-analysis, comprising 12 386 screened people. Eleven studies (7020 patients) evaluated the presence of S. stercoralis infection only through investigation of larvae in faeces, showing an overall prevalence of 1% (95%CI 1-1%). Thirteen studies (5366 patients) used a serological test, showing an overall prevalence of 14% (95%CI 11-17%). Strongyloidiasis seroprevalence was 20% (95%CI 15-24%) among migrants from sub-Saharan Africa, 14% (95%CI 10-18%) among those from Latin America and 8% (95%CI 5-11%) among migrants from North Africa.
CONCLUSIONS: Migrants coming from strongyloidiasis-endemic areas living in Spain had a high S. stercoralis infection prevalence, particularly those from sub-Saharan Africa and Latin America. This population should be screened using serology as the most sensitive test for S. stercoralis infection. This could be easily implemented at primary care level.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Strongyloides stercoraliszzm321990; dépistage; migrants; screening; serology; strongyloidiasis; strongyloïdose; sérologie

Mesh:

Year:  2019        PMID: 31758828     DOI: 10.1111/tmi.13352

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  4 in total

1.  Proteomic analysis of the excretory-secretory products from Strongyloides venezuelensis infective larvae: new insights for the immunodiagnosis of human strongyloidiasis.

Authors:  William Henry Roldán Gonzáles; Guilherme Rabelo Coelho; Daniel Carvalho Pimenta; Fabiana Martins de Paula; Ronaldo Cesar Borges Gryschek
Journal:  Parasitol Res       Date:  2022-08-31       Impact factor: 2.383

2.  Asymptomatic Strongyloidiasis among Latin American Migrants in Spain: A Community-Based Approach.

Authors:  Violeta Ramos-Sesma; Miriam Navarro; Jara Llenas-García; Concepción Gil-Anguita; Diego Torrús-Tendero; Philip Wikman-Jorgensen; Concepción Amador-Prous; María-Paz Ventero-Martín; Ana-María Garijo-Sainz; María García-López; Ana-Isabel Pujades-Tárraga; Cristina Bernal-Alcaraz; Antonio Santonja; Pedro Guevara-Hernández; María Flores-Chávez; José-María Saugar; José-Manuel Ramos-Rincón
Journal:  Pathogens       Date:  2020-06-24

3.  Effectiveness and Safety of a Single-Dose Ivermectin Treatment for Uncomplicated Strongyloidiasis in Immunosuppressed Patients (ImmunoStrong Study): The Study Protocol.

Authors:  Fernando Salvador; Ana Lucas-Dato; Silvia Roure; Marta Arsuaga; Asunción Pérez-Jacoiste; Magdalena García-Rodríguez; José A Pérez-Molina; Dora Buonfrate; José María Saugar; Israel Molina
Journal:  Pathogens       Date:  2021-06-27

4.  Clinical value of serology for the diagnosis of strongyloidiasis in travelers and migrants: A 4-year retrospective study using the Bordier IVD® Strongyloides ratti ELISA assay.

Authors:  Brice Autier; Sarrah Boukthir; Brigitte Degeilh; Sorya Belaz; Anne Dupuis; Sylviane Chevrier; Jean-Pierre Gangneux; Florence Robert-Gangneux
Journal:  Parasite       Date:  2021-12-06       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.